168
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Coexistence of fibromyalgia and post-polio syndrome in persons with prior poliomyelitis in Turkey: the relations with symptoms, polio-related impairments, and quality of life

, , & ORCID Icon
Pages 3511-3518 | Received 23 Feb 2022, Accepted 18 Sep 2022, Published online: 28 Sep 2022

References

  • Halstead LS, Rossi CD. New problems in old polio patients: results of a survey of 539 polio survivors. Orthopedics. 1985;8(7):845–850.
  • On AY. Post-polio syndrome. Turk J Phys Med Rehab. 2008;54:164–173.
  • On AY, Oncu J, Atamaz F, et al. Impact of post-polio-related fatigue on quality of life. J Rehabil Med. 2006;38(5):329–332.
  • Vincent A, Lahr BD, Wolfe F, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rrochester Epidemiology Project. Arthritis Care Res. 2013;65(5):786–792.
  • Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38(6):1113–1122.
  • Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356.
  • Marques AP, Santo ASDE, Berssaneti AA, et al. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017;57(4):356–363.
  • Branco JC, Bannwarth B, Failde I, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010;39(6):448–453.
  • Prateepavanich P, Petcharapiruch S, Leartsakulpanitch J. Estimating the prevalence of fibromyalgia and its impacts on health in Thais: a community-survey in Bangkok, Thailand [abstract. ]. Value Health. 2012;15(7):A678.
  • McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007;21(3):403–425.
  • Wolfe F, Brähler E, Hinz A, et al. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res. 2013;65(5):777–785.
  • Jones GT, Atzeni F, Beasley M, et al. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 2015;67(2):568–575.
  • Häuser W, Brähler E, Ablin J, et al. Modified 2016 American College of Rheumatology Fibromyalgia Criteria, the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks-American Pain Society Pain Taxonomy, and the Prevalence of Fibromyalgia. Arthritis Care Res. 2021;73(5):617–625.
  • Turhanoğlu AD, Yilmaz Ş, Kaya S, et al. The epidemiological aspects of fibromyalgia syndrome in adults living in Turkey: a population based study. J Musculoskelet Pain. 2008;16(3):141–147.
  • Topbas M, Cakirbay H, Gulec H, et al. The prevalence of fibromyalgia in women aged 20–64 in Turkey. Scand J Rheumatol. 2005;34(2):140–144.
  • March of Dimes. Post-polio syndrome: identifying best practices in diagnosis & care. White Plains (NY): March of Dimes; 2001.
  • Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–172.
  • Qureshi AG, Jha SK, Iskander J, et al. Diagnostic challenges and management of fibromyalgia. Cureus. 2021;13(10):e18692.
  • Wolfe F, Clauw D, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–610.
  • Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319–329.
  • Trojan DA, Cashman NR. Fibromyalgia is common in a postpoliomyelitis clinic. Arch Neurol. 1995;52(6):620–624.
  • On AY. Polio survivors in Turkey. Post Polio Health. 2015;31(4):3–7.
  • Ertem M, Sarac A, Tumay S. Poliomyelitis eradication programme: acute flaccid paralysis surveillance in Mardin and five other provinces around Mardin, Turkey 1998. Public Health. 2000;114(4):286–290.
  • Medical Research Council of the United Kingdom. Aiak to examination of the penphera1 nervous system: Memorandum No 45. Palo Alto (CA): Pedragon House; 1978.
  • Brogårdh C, Lexell J. Test-Retest reliability of the Self-Reported ımpairments in persons With late effects of polio (SIPP) rating scale. PM R. 2016;8(5):399–404.
  • Brogårdh C, Lexell J, Lundgren-Nilsson A. Construct validity of a new rating scale for self-reported impairments in persons with late effects of polio. PM R. 2013;5(3):176–181; quiz 181.
  • Huskisson EC. Measurement of pain. Lancet. 1974;304(7889):1127–1131.
  • Vasconcelos OM, Jr, Prokhorenko OA, Kelley KF, et al. A comparison of fatigue scales in postpoliomyelitis syndrome. Arch Phys Med Rehabil. 2006;87(9):1213–1217.
  • Koopman FS, Brehm MA, Heerkens YF, et al. Measuring fatigue in polio survivors: content comparison and reliability of the Fatigue Severity Scale and the Checklist Individual Strength. J Rehabil Med. 2014;46(8):761–767.
  • Oncu J, Atamaz F, Durmaz B, et al. Psychometric properties of fatigue severity and fatigue impact scales in postpolio patients. Int J Rehabil Res. 2013;36(4):339–345.
  • Kücükdeveci AA, McKenna SP, Kutlay S, et al. The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res. 2000;23(1):31–38.
  • Razali NM, Wah YB. Power comparisons of Shapiro-Wilk, Kolmogorov-Smirnov, Lilliefors and Anderson-Darling tests. JOSMA. 2011;2(1):21–33.
  • Tsagris M, Alenazi A, Verrou KM, et al. Hypothesis testing for two population means: parametric or non-parametric test? J Stat Comput Simul. 2020;90(2):252–270.
  • de Winter JC, Gosling SD, Potter J. Comparing the Pearson and Spearman correlation coefficients across distributions and sample sizes: a tutorial using simulations and empirical data. Psychol Methods. 2016;21(3):273–290.
  • Wolfe F, Fitzcharles MA, Goldenberg DL, et al. Comparison of physician-based and patient-based criteria for the diagnosis of fibromyalgia. Arthritis Care Res. 2016;68(5):652–659.
  • Gur M, Gulkesen A, Akgol G. Comparison of ACR 1990 and ACR 2010 classification criteria in fibromyalgia syndrome. Med Science. 2019;8(4):975–979.
  • On AY, Aykanat D, Atamaz FC, et al. Is it necessary to strictly diagnose fibromyalgia syndrome in patients with chronic widespread pain? Clin Rheumatol. 2015;34(8):1473–1479.
  • Ablin JN, Wolfe F. A comparative evaluation of the 2011 and 2016 criteria for fibromyalgia. J Rheumatol. 2017;44(8):1271–1276.
  • Fontaine KR, Conn L, Clauw DJ. Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Res Ther. 2010;12(2):R55.
  • Kayo AH, Peccin MS, Sanches CM, et al. Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatol Int. 2012;32(8):2285–2292.
  • Trojan DA, Cashman NR. Pathophysiology and diagnosis of post-polio syndrome. NeuroRehabilitation. 1997;8(2):83–92.
  • Bennett RM, Clark SR, Campbell SM, et al. Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum. 1992;35(10):1113–1116.
  • Wolfe F, Ross K, Anderson J, et al. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol. 1995;22(1):151–156.
  • Schiltenwolf M, Pogatzki-Zahn EM. Pain medicine from intercultural and gender-related perspectives. Schmerz. 2015;29(5):569–75575.
  • Aggarwal VR, McBeth J, Zakrzewska JM, et al. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int J Epidemiol. 2006;35(2):468–476.
  • Siracusa R, Paola RD, Cuzzocrea S, et al. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021;22(8):3891.
  • Drozd M, Marzęda M, Blicharz A, et al. Unclear etiology and current hypotheses of the pathogenesis of fibromyalgia. J Educ Health Sport. 2020;10(9):338–344.
  • Staud R, Vierck CJ, Cannon RL, et al. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain. 2001;91(1–2):165–175. Mar
  • Montoro CI, Duschek S, Ladrón de Guevara CM, et al. Patterns of cerebral blood flow modulation during painful stimulation in fibromyalgia: a transcranial doppler sonography study. Pain Med. 2016;17(12):2256–2267.
  • Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008;37(6):339–352.
  • Duffield SJ, Miller N, Zhao S, et al. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2018;57(8):1453–1460.
  • On A. Fibromyalgia in rheumatic diseases. Ege J Med. 2019;58:37–41.
  • Fan A, Pereira B, Tournadre A, et al. Frequency of concomitant fibromyalgia in rheumatic diseases: monocentric study of 691 patients. Semin Arthritis Rheum. 2017;47(1):129–132.
  • Haliloglu S, Carlioglu A, Akdeniz D, et al. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int. 2014;34(9):1275–1280.
  • Meeus M, Vervisch S, De Clerck LS, et al. Central sensitization in patients with rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum. 2012;41(4):556–567.
  • Mease PJ, Hanna S, Frakes EP, et al. Pain mechanisms in osteoarthritis: understanding the role of Central pain and current approaches to its treatment. J Rheumatol. 2011;38(8):1546–1551.
  • (a) On AY, Uludağ B, Taşkiran E, et al. Differential corticomotor control of a muscle adjacent to a painful joint. Neurorehabil Neural Repair. 2004;18(3):127–133. (b) Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547–1555.
  • Hernando-Garijo I, Jiménez-Del-Barrio S, Mingo-Gómez T, et al. Effectiveness of non-pharmacological conservative therapies in adults with fibromyalgia: a systematic review of high-quality clinical trials. J Back Musculoskelet Rehabil. 2022;35(1):3–20.
  • Tzadok R, Ablin JN. Current and emerging pharmacotherapy for fibromyalgia. Pain Res Manag. 2020;2020:6541798.
  • On AY, Oncu J, Uludag B, et al. Effects of lamotrigine on the symptoms and life qualities of patients with postpolio syndrome: a randomized, controlled study. NeuroRehabilitation. 2005;20(4):245–251.
  • Wiffen PJ, Derry S, Moore RA. Lamotrigine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2013;2013(12):CD006044.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.